Tech Company Financing Transactions

Hopewell Therapeutics Funding Round

Hopewell Therapeutics secured a $25 million Seed funding round on 6/7/2023. Investors included 5Y Capital, Bopu Capital Management and Hike Capital.

Transaction Overview

Announced On
6/7/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Seed
Proceeds Purpose
The funds will enable the company to advance the development of genomic medicines based on its differentiated ttLNP platform through both internal pipeline programs and external partnerships.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
216 W Cummings Park
Woburn, MA 01801
USA
Email Address
Overview
Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry leading companies. We are developing our own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of our ttLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases and neurological disorders.
Profile
Hopewell Therapeutics LinkedIn Company Profile
Social Media
Hopewell Therapeutics Company Twitter Account
Company News
Hopewell Therapeutics News
Facebook
Hopewell Therapeutics on Facebook
YouTube
Hopewell Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas Hennessey
  Thomas Hennessey LinkedIn Profile  Thomas Hennessey Twitter Account  Thomas Hennessey News  Thomas Hennessey on Facebook
Chief Scientific Officer
Kate Zhang
  Kate Zhang LinkedIn Profile  Kate Zhang Twitter Account  Kate Zhang News  Kate Zhang on Facebook
Founder
Qiaobing Xu
  Qiaobing Xu LinkedIn Profile  Qiaobing Xu Twitter Account  Qiaobing Xu News  Qiaobing Xu on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/7/2023: Mosaic venture capital transaction
Next: 6/7/2023: Source.ag venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary